Evidence map›Paper›PMID 40736901›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

A Draft Genome Assembly for the Neglected Tropical Fungal Disease Pathogen Emarellia grisea and Comparison to Other Pleosporalean Agents Causing Eumycetoma in Humans.

Aleksandra D Chybowska, Nicolas Helmstetter, Dunstan Rajendram, David Bibby, Andrew M Borman, Rhys A Farrer

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aleksandra D ChybowskaInstitute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK.
Nicolas HelmstetterMedical Research Council, Centre for Medical Mycology, University of Exeter, Exeter, UK.
Dunstan RajendramGastrointestinal Bacteria Reference Unit, UK Health Security Agency, London, UK.
David BibbyAntiviral Unit, UK Health Security Agency, London, UK.
Andrew M BormanMedical Research Council, Centre for Medical Mycology, University of Exeter, Exeter, UK. Andy.Borman@nbt.nhs.uk.
Rhys A FarrerMedical Research Council, Centre for Medical Mycology, University of Exeter, Exeter, UK. R.Farrer@exeter.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycetoma is a neglected tropical disease, characterized by slowly evolving tumorous subcutaneous masses containing either bacteria (e.g., Actinomycetoma) or fungi (e.g., Eumycetoma; Madura foot). The fungal agents of mycetoma, including several genera belonging to the Pleosporales order of Ascomycetes, were designated high-priority pathogens in the WHO Fungal Priority Pathogens List of 2023 to signal the need for additional research and development and public health action. Despite this, many of the fungal causative agents are poorly described, especially in terms of the genomic basis for disease, their epidemiology, and evolutionary history. Recently, the new genus Emarellia was described, including two sister species, E. grisea and E. paragrisea. To gain insights into the virulence and/or pathogenicity features of eumycetoma, we describe the first genome assembly and gene annotation for Emarellia grisea and compare this genome assembly to those currently available for other agents of eumycetoma and close relatives, Madurella mycetomatis and Trematosphaeria pertusa. We also describe the gene annotation for the genome assembly of Nigrograna (formerly Biatriospora) mackinnonii, which hitherto lacked annotation. Our genome assembly comprises 691 contigs representing 28.23 Mb of sequence, with very low repeat content. Genes uniquely encoded by E. grisea included an enrichment of secretion signals, suggesting possible new virulence factors. We also found that E. grisea produces a diverse array of endo- and exopeptidases, which may contribute to its virulence and drug resistance. We anticipate that our genomic resource and analysis will benefit future studies on the genomic basis for pathogenicity in neglected fungal agents causing eumycetoma or similar subcutaneous lesions in humans.

Indexed as

AscomycotaGenome, FungalMycetomaGenomicsHumansMolecular Sequence AnnotationNeglected DiseasesPhylogenyAnnotationAssemblyBiatriosporaEmarellia griseaEumycetomaInfections of implantationMadurellaNeglected fungal tropical diseaseTrematosphaeriaWhole genome sequence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.